Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2

by Jackson, R.A., Murali, S., Nurcombe, V., Cool, S.M., Van, Wijnen A.J., Stein, G.S.
Published 2011

Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer

by Das, K., Putti, T., Salto-Tellez, M., Leong, D.T., Gupta, A., van, Wijnen A.J., Shen, L., Stein, G.S.
Published 2012

Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes

by Yan, D., Chen, D., Cool, S.M., van Wijnen, A.J., Mikecz, K., Murphy, G., Im, H.-J.
Published 2014

Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells

by Ling, L., Murali, S., Dombrowski, C., Haupt, L.M., Nurcombe, V., Cool, S.M., Stein, G.S., Van, Wijnen A.J.
Published 2011

Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy

by Ling L., Tan S.K., Goh T.H., Cheung E., VICTOR NURCOMBE, van Wijnen A.J., Cool S.M.
Published 2020

Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription

by Afzal, F., Pratap, J., Stein, J.L., Van, Wijnen A.J., Stein, G.S., Lian, J.B., Javed, A., Ito, K., Ito, Y.
Published 2011

Human mesenchymal stem cells retain multilineage differentiation capacity including neural marker expression after extended in vitro expansion

by Okolicsanyi R.K., Camilleri E.T., Oikari L.E., Yu C., Cool S.M., Van Wijnen A.J., Griffiths L.R., Haupt L.M.
Published 2019

FGFR1 signaling stimulates proliferation of human mesenchymal stem cells by inhibiting the cyclin-dependent kinase inhibitors p21Waf1 and p27Kip1

by Dombrowski, C., Helledie, T., Ling, L., Grünert, M., Canning, C.A., Jones, C.M., Hui, J.H., Nurcombe, V., Van Wijnen, A.J., Cool, S.M.
Published 2014

Subnuclear targeting of the Runx3 tumor suppressor and its epigenetic association with mitotic chromosomes

by Pande, S., Ali, S.A., Dowdy, C., Zaidi, S.K., Lian, J.B., Stein, J.L., Van, Wijnen A.J., Stein, G.S., Ito, K., Ito, Y., Montecino, M.A.
Published 2011

Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma

by Nathan, S.S., Pereira, B.P., Pho, R.W.H., Van, Wijnen A.J., Zhou, Y.-F., Gupta, A., Soong, R., Salto-Tellez, M., Dombrowski, C., Cool, S.M., Stein, G.S.
Published 2012

Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma

by Nathan, S.S., Pereira, B.P., Pho, R.W.H., Van, Wijnen A.J., Zhou, Y.-F., Gupta, A., Soong, R., Salto-Tellez, M., Dombrowski, C., Cool, S.M., Stein, G.S.
Published 2011

Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1)

by Pereira, B.P., Aung, K.Z., Pho, R.W.H., Cool, S.M., Nathan, S.S., Zhou, Y., Gupta, A., Leong, D.T., Salto-Tellez, M., Van, Wijnen A.J., Ling, L., Galindo, M., Stein, G.S.
Published 2011

Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new pre-chemotherapeutic osteosarcoma cell line (OS1)

by Pereira, B.P., Aung, K.Z., Pho, R.W.H., Cool, S.M., Nathan, S.S., Zhou, Y., Gupta, A., Leong, D.T., Salto-Tellez, M., Van, Wijnen A.J., Ling, L., Galindo, M., Stein, G.S.
Published 2012

Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility

by Leong, D.T., Lim, J., Goh, X., Pratap, J., Pereira, B.P., Kwok, H.S., Nathan, S.S., Dobson, J.R., Lian, J.B., Ito, Y., Voorhoeve, P.M., Stein, G.S., Salto-Tellez, M., Cool, S.M., van Wijnen, A.J.
Published 2014

Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfβ in osteosarcoma cells

by San Martin, I.A., Varela, N., Gaete, M., Villegas, K., Osorio, M., Tapia, J.C., Antonelli, M., Mancilla, E.E., Pereira, B.P., Nathan, S.S., Lian, J.B., Stein, J.L., Stein, G.S., Van Wijnen, A.J., Galindo, M.
Published 2014

Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice...

by Camilleri, E.T, Gustafson, M.P, Dudakovic, A, Riester, S.M, Garces, C.G, Paradise, C.R, Takai, H, Karperien, M, Cool, S, Sampen, H.-J.I, Larson, A.N, Qu, W, Smith, J, Dietz, A.B, Van Wijnen, A.J
Published 2020

Enhancing the Efficacy of Stem Cell Therapy with Glycosaminoglycans

by Ling, L., Ren, X., Cao, X., Hassan, A.B.M., Mah, S., Sathiyanathan, P., Smith, R.A.A., Tan, C.L.L., Eio, M., Samsonraj, R.M., van Wijnen, A.J., Raghunath, M., Nurcombe, V., Hui, J.H., Cool, S.M.
Published 2021

MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma

by Van Der Deen, M., Taipaleenmäki, H., Zhang, Y., Teplyuk, N.M., Gupta, A., Cinghu, S., Shogren, K., Maran, A., Yaszemski, M.J., Ling, L., Cool, S.M., Leong, D.T., Dierkes, C., Zustin, J., Salto-Tellez, M., Ito, Y., Bae, S.-C., Zielenska, M., Squire, J.A., Lian, J.B., Stein, J.L., Zambetti, G.P., Jones, S.N., Galindo, M., Hesse, E., Stein, G.S., Van Wijnen, A.J.
Published 2014